Table 2.
CVP group n = 45 |
SV group n = 45 |
SV & DPX group n = 45 |
P | |
---|---|---|---|---|
Intra-operative period | ||||
Intravenous crystalloid during surgery (ml) | 3595 (1354) | 4057 (1495) | 4159 (1393) | 0.15 |
Intravenous colloid during surgery (ml) | 756 (815) | 835 (688) | 709 (559) | 0.69 |
Intervention period | ||||
Intravenous crystalloid during study period (ml) | 639 (281) | 652 (237) | 626 (250) | 0.98 |
Intravenous colloid during study period (ml) | 1104 (553) | 1227 (555) | 1307 (549) | 0.22 |
Patients receiving vasopressor therapy (%) | 7 (16%) | 8 (18%) | 5 (11%) | 0.82 |
Data presented as mean (standard deviation) or absolute values (%). CVP, central venous pressure; DPX, dopexamine; SV, stroke volume.